Top Markets
#1 Velas Velas +367.72%
#2 Gravity Gravity +48.70%
#3 Galxe Galxe +41.28%
#4 Infinity Ground Infinity Ground +30.80%
#5 Wiki Cat Wiki Cat +26.84%
#6 Audiera Audiera +26.57%
#7 Fetch.ai Fetch.ai +26.24%
#8 Derive Derive +24.86%
#9 Aria.AI Aria.AI +20.75%
#10 Babylon Babylon +18.83%
Coin of the day
Velas Velas
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rang in Aktien #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aktienkurs
$38.41
Marktkapitalisierung
$170.67B
Veränderung (1 Tag)
1.17%
Veränderung (1 Jahr)
-49.92%
Land
DK
Handel Novo Nordisk A/S (NVO)

Kategorie

Healthcare
Marktkapitalisierung
Umsatz
mehr
Gewinn
Kursverlauf
KGV
KUV
KBV
Operative Marge
EPS
Aktiensplits
Dividenden
Dividendenrendite
Ausstehende Aktien
Aktien-Split-Historie für Novo Nordisk A/S (NVO)
Die Aktie Novo Nordisk A/S (Symbol: NVO) durchlief insgesamt 3 Aktiensplits.
Der letzte Aktiensplit fand am Sep 13, 2023 statt.
Eine NVO-Aktie, die vor dem Jan 25, 2008 gekauft wurde, entspricht heute 20 NVO-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2023-09-13 2:1 x2 x20
2014-01-02 5:1 x5 x10
2008-01-25 2:1 x2 x2
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 0 -
US
UCB SA UCB SA
UCB SA
UCB.BR
 0 -
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL